Infertility, Male
Conditions
Keywords
magnetic activated sperm sorting, DNA fragmentation index, sperm up, density differential centrifugation, clinical outcome
Brief summary
Recent studies have evaluated the use of magnetic-activated sperm sorting (MASS) to reduce apoptotic spermatozoa and improve the outcome of infertile male with assisted reproductive technology (ART). However, some results were inconsistent with above. The sperm of male with abnormal semen analysis tend to be accompanied with high apoptotic and high DNA fragmentation index (DFI). Hence, this study aimed at determining the efficiency of MASS in improving the clinical outcome of patients with high DFI).
Detailed description
Patients will be recruited from our reproductive medicine center in Nanjing Drum towel Hospital, from July 2019 to July 2020. After semen analysis and selection of infertile men with at least two abnormal sperm parameters and obtaining the informed consent of the patients according to the admission criteria, the patients who enter the project will be randomly divided into the control group (n=30) whose sperm will be screened by density differential centrifugation (DGC) with swim up, and the observation group will be screened by MASS, followed by DGC. Then the procedure of in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) will be performed. Embryo transfer will be underwent according to the developmental speed and morphological characteristics of the embryo. The clinical outcomes after transplantation will be followed up.
Interventions
PROCEDUREMagnetic activated sperm sorting
MACS is a technique which allows the spermatozoa with the best characteristics to be selected for use in assisted reproduction treatments. This technique removes apoptotic spermatozoa - those which will die without achieving fertilisation - and selects the healthy ones, thus increasing the possibility of pregnancy.
Sponsors
Li-jun Ding
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
MALE
Age
20 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
* Patients were diagnostic as infertile according to 2007 WHO guidelines; * DFI\>25%.
Exclusion criteria
* With obvious female infertile factors; * Sperm count \<10 million; * Chromosomal abnormalities in either or both of the couple; * Loss of follow up or incomplete information of patients.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pregnancy rate | 2-3 months | Pregnancy rate was defined from posi tive blood HCG and ultrasonography findings showing at least one embryo with a foetal heart beat 5 weeks after transfer. |
| Implantation rate | 2-3 months | Implantation rate means the percentage of those embryos that implanted themselves into the uterine lining after having been transferred to the womb. Fetal heartbeat can be visualized via ultrasound in order to definitely confirm the implantation of the embryo. |
| Live-birth rate | 1year | Live birth rate was defined as the number of deliveries that resulted in a live born neonate. |
Countries
China
Contacts
Primary ContactHaixiang Sun, phD
Backup ContactLijun Ding, phD
Outcome results
None listed